Insights
Can TMS Be Done at Home?
If you've searched for at-home TMS, you've probably found a confusing mix: devices that sound like TMS but aren't, machines for sale that shouldn't be, and — as of late 2025 — one genuinely new FDA-approved option that changes part of the answer. Here's the honest picture.
TMS itself: no, and here's why
Transcranial magnetic stimulation cannot be done at home, and there is no FDA-cleared at-home TMS device. That's not gatekeeping — it follows from what TMS is. A clinical TMS system generates strong, precisely targeted magnetic pulses, and safe treatment depends on things that only work in a supervised setting: mapping your individual motor threshold to calibrate the dose, positioning the coil on the exact brain region being treated, and having trained staff present because TMS carries a very small seizure risk that clinics are equipped to manage. The machines themselves are large, powerful clinical devices — which is also why you should steer well clear of used "TMS machines" listed on resale sites. Clinical equipment without calibration, targeting, and supervision isn't home treatment; it's a hazard.
What's actually sold for home use
The devices marketed for home use are different technologies that are easy to confuse with TMS. The most common are CES devices — cranial electrotherapy stimulation, such as the Fisher Wallace Stimulator — which apply a low-level electrical current and sit in a different FDA category, with the Class II clearance pathway covering anxiety and insomnia. And there's tDCS — transcranial direct current stimulation — which applies a weak direct current through electrodes on the scalp. Neither is TMS: the currents involved are a fraction of the energy of a TMS pulse, and the evidence base, indications, and regulatory status are all their own.
The new development: an FDA-approved at-home device (that isn't TMS)
In December 2025, the FDA approved the first at-home brain stimulation device specifically for depression: the Flow Neuroscience FL-100, a prescription tDCS headset. It's approved for adults with moderate to severe major depressive disorder, used on its own or alongside medication, and it began reaching the U.S. market in 2026. In its ten-week randomized trial, active stimulation outperformed sham, with remission and response rates roughly two to three times higher, and the common side effects were mild — skin tingling or irritation at the electrode sites and occasional headache.
That approval is genuinely good news: it expands access to a non-drug option for people who can't easily get to a clinic. And it's worth being equally clear about what it is not. It is not TMS — it's a different technology at far lower intensity — and its FDA approval specifically covers patients who are not considered treatment-resistant to medication. That last detail matters more than it sounds.
Which tool fits which situation
Read the indications side by side and a clean picture emerges. The at-home device is approved for people with depression who haven't exhausted medication options — a first-line or alongside-medication tool. TMS occupies the opposite lane: it's the FDA-cleared, insurance-covered option specifically for people whose depression has not responded adequately to antidepressant medication. If you've tried two or more antidepressants without enough relief, you're in the population the home device's approval excludes — and squarely in the population TMS was cleared for, with nearly two decades of clinical use behind it.
Neither tool is "better" in the abstract; they're for different people at different points. Someone early in treatment who can't reach a clinic may be well served asking their prescriber about the home option. Someone several medications deep, still struggling, is the person clinic-based TMS exists for — and that evaluation is worth having with a psychiatrist who can look at the whole picture.
If the barrier is time, not distance
A lot of interest in home treatment is really about the schedule: standard TMS means roughly twenty-minute sessions, five days a week, for several weeks. If that's the obstacle, it's worth knowing the in-clinic answer has changed too — accelerated TMS with theta burst stimulation (iTBS) delivers an FDA-cleared session in as little as about three minutes, which turns treatment into something that fits inside a lunch break. We offer accelerated protocols at our Aurora clinic.
The bottom line
TMS remains a clinic-based treatment, and anything sold as at-home TMS isn't TMS. A real at-home option now exists in the form of an FDA-approved tDCS device — a meaningful new tool for the right patient, and a different tool from TMS with a different approved population. If your depression hasn't responded to medication, that's precisely the situation TMS is cleared and covered for. A free consultation is available any hour — in English or Spanish — at 720-500-7873. And if you're trying to put numbers to how you've been feeling first, our free, private PHQ-9 depression screening takes about two minutes.